Alnylam Pharmaceuticals
ALNY
#549
Rank
HK$355.95 B
Marketcap
HK$2,684
Share price
1.22%
Change (1 day)
37.75%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company